SynthesisActa anaesthesiologica Scandinavica2026
Bicarbonate and Other Buffer Therapies in Acute Metabolic Acidosis: A Systematic Review and Meta-Analysis.
Synthesis in Acta anaesthesiologica Scandinavica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe aim of this study was to perform a systematic review and meta-analysis on the effect of buffering therapies on clinical outcomes in adult patients with acute metabolic acidosis.
methodsSearches were conducted in Embase, Cochrane, and PubMed for randomised clinical trials comparing a buffering therapy to either placebo, no buffering therapy, or another buffering therapy in adult patients with acute metabolic acidosis. Two assessors independently reviewed trials for relevance, extracted data, and assessed risk of bias using the Cochrane Risk of bias 2 tool. Meta-analyses were performed using fixed-effect models. The certainty of evidence was assessed using the GRADE methodology.
resultsFifteen manuscripts representing 14 trials were included. Most trials were conducted in critically ill patients (4 trials; n = 1064), in patients with out-of-hospital cardiac arrest (3 trials; n = 1426), or in patients with intraoperative acidosis (3 trials; n = 136). In most trials, the intervention was bicarbonate. Risk of bias was assessed as moderate for most trials. In ICU patients with acute kidney injury, buffering therapy probably has no large effect on survival outcomes (low certainty), but likely reduces the use of renal replacement therapy and the rate of bloodstream infections (moderate certainty). Buffering therapy likely does not have an effect on survival outcomes in patients with out-of-hospital cardiac arrest (very low to low certainty).
conclusionBuffering therapy in ICU patients with acute kidney injury likely has beneficial effects on the use of renal replacement therapy, but probably no effect on survival outcomes. Similarly, no effects were found for survival outcomes in patients with out-of-hospital cardiac arrest. EDITORIAL COMMENT: This systematic review with meta-analysis presents an up to date and trustworthy synthesis of evidence concerning buffer therapy in acute metabolic acidosis, largely focused in the critical care context.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.